| 000 | 02570cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223031255.0 | ||
| 008 | 150809s2014 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.19.M.Sc.2014.Sa.S | ||
| 100 | 0 | _aSarah Mahmoud Elsayed Ouda | |
| 245 | 1 | 0 |
_aSerum beta- 2 microglobulin level : _bA possible marker for disease progression in Egyptian patients with chronic HCV related liver diseases / _cSarah Mahmoud Elsayed Ouda ; Supervised Mikhail Nasr Mikhail , Ashraf Elsayed Abdelhamied , Ahmed Mohamed Khairy |
| 246 | 1 | 5 |
_aبيتا-2 ميكروجلوبيولين المصلى : _bدلالة ممكنة لتطور المرض عند المرضى المصريين المصابين بإلتهاب كبدى(ج) المزمن و أمراض الكبد المرتبطة بة |
| 260 |
_aCairo : _bSarah Mahmoud Elsayed Ouda , _c2014 |
||
| 300 |
_a158 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Microbiology and Immunology | ||
| 520 | _aBeta - 2 microglobulin (v2M) is responsible for transmission of viral antigens on the surface of cells as part of HLA complex. Normal serum levels are less than 3æg / ml. It increases in inflammatory and malignant conditions including HCV infection. Determining the concentration of serum v2M levels in patients with HCV related chronic hepatitis, cirrhosis, and hepatocellular carcinoma and correlate the results with clinical parameters for disease progression. In this analytical cross sectional study 92 participants were included in 4 equal groups: Group (1) non cirrhotic chronic HCV, Group (2):HCV related liver cirrhosis, Group (3): HCC on top of HCV, Group (4): healthy controls. History taking, clinical examination ,routine labs, and US were done to all patients. Group specific inclusion criteria: PCR, metavir score for group (1) patients. CT and AFP for Group (3) patients. v2M levels were measured in serum by ELISA. Quantitative variables presented by number and percent were compared by chi - square or fisher's exact test | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aHCC | |
| 653 | 4 | _aHCV progression | |
| 653 | 4 | _aSerum B2M | |
| 700 | 0 |
_aAhmed Mohamed Khairy , _eSupervisor |
|
| 700 | 0 |
_aAshraf Elsayed Abdelhamied , _eSupervisor |
|
| 700 | 0 |
_aMikhail Nasr Mikhail , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c51884 _d51884 |
||